Evolent Health (EVH) Misses Q2 EPS by 18c

Evolent Health (NYSE: EVH) reported Q2 EPS of ($0.10), $0.18 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $444.33 million versus the consensus estimate of $459.4 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• PepsiCo (PEP) Misses Q2 EPS by 1c, Beats on Revenue
• U.S. strikes damage Iran railway bridge linking to China and Russia, Fars says
• Baird Reiterates Outperform Rating on Costco Wholesale (COST)